Goodwin on Medtech

Insights and resources covering the latest medtech trends influencing your business

Goodwin’s global Medtech practice is a one-stop shop for innovators bringing breakthrough medical technologies to market, providing comprehensive guidance on everything from corporate and transactions to intellectual property strategy and regulatory compliance. Explore our latest perspectives.

Corporate and Transactional
Fundraising Strategies for Early-Stage Medtech Startups
Read More
Corporate and Transactional
Medtech M&A and Venture Investments Show Renewed Strength
Read More
Intellectual Property
Four Steps to Maximize the Value of AI Innovation in Medtech
Read More
Regulations
How the EU AI Act Could Affect Medtech Innovation
Read More
Regulations
Quarterly Issue Tracker: Life Sciences Regulations — Q1 2025 and Beyond
Read More
Regulations
FDA Approvals of AI Medical Devices Rise Rapidly
Read More
Intellectual Property
Inventing With AI
Read More
Regulations
The FDA’s 510(k) Program Guidance: Predicate Device Selection and Clinical Data Usage
Read More

Find Us at Our Next Event

Join members of the Medtech practice at the annual Goodwin Rare Disease Symposium in Boston on February 5. The program will feature a range of voices and perspectives from the rare disease community.

Past Medtech Events

Members of the Medtech practice attended the 43rd JPM Healthcare Conference in San Francisco, CA. Goodwin and KPMG hosted the 6th Annual Symposium @ JP Morgan on January 15, 2025. At the symposium, we delved into strategies that enable life sciences companies to enhance research and development; optimize value from licensing, M&A, and other transactions; and secure capital from growth.